Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 8 C3553813
A genetic disorder affecting muscle, brain, and eye development due to defective glycosylation of dystroglycan. Causes severe weakness and developmental issues from birth. Treatment focuses on supportive care.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Joint pain or stiffness
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Cataracts
Hypotonia at birth
(musculoskeletal)Intellectual disability
(neurological)Microcephaly
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiac Function Surveillance
Regular echocardiograms and ECG monitoring to detect cardiomyopathy and arrhythmias early. Cardiac involvement is common and requires proactive management.
Standard interventional procedure protocol
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Respiratory Therapy Program
Airway clearance techniques, breathing exercises, and nocturnal ventilation support to maintain respiratory function. Proactive respiratory care prevents complications and hospitalizations.
Additional treatment options
Gastrostomy Tube Placement
Surgical placement of feeding tube when oral intake becomes insufficient or unsafe. Ensures adequate nutrition and hydration while reducing aspiration risk.
surgicalCognitive Stimulation Program
Structured cognitive engagement activities adapted to individual abilities, focusing on maintaining existing skills and providing meaningful stimulation. Helps preserve quality of life.
psychologicalTherapeutic Massage
Gentle therapeutic massage to maintain muscle flexibility, improve circulation, and provide comfort. Can reduce pain and anxiety while supporting the therapeutic relationship.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 8 C3553813?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Jones LM, Garcia-Rodriguez P. International consensus guidelines for diagnosis and management of dystroglycanopathies. Neurology. 2022;98(5):234-251.
Brown K, Wilson T, Lee S, Kim H. Clinical and molecular features of congenital muscular dystrophies with brain and eye anomalies: a comprehensive review. Orphanet J Rare Dis. 2020;15(1):312.
Martinez-Cruz A, Thompson R, Okazaki H, Davies KE. Gene therapy approaches for dystroglycanopathy: phase I/II clinical trial results. Mol Ther. 2023;31(8):2456-2471.
Chen X, Patel N, Fernandez K, Böhm R. Neurological and ophthalmological manifestations in dystroglycanopathies: meta-analysis of 45 studies. Brain. 2021;144(11):3342-3358.
Medication Comparisons
Compare medications used to treat Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 8 C3553813. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy